Join our
Investor Newsletter

To receive Investor News as it is released please sign up

News Releases

U.S. CPT® Code Granted for KidneyIntelX™

July 1, 2019
CPT Code a key component for reimbursement from private medical insurance and Medicare   NEW YORK, July 1, 2019 /PRNewswire/ --  Renalytix AI plc  (LON: RENX), a developer of artificial intelligence-enabled clinical diagnostics for kidney disease, announced today that the American Medical

FDA Grants Breakthrough Device Designation to KidneyIntelX™

May 2, 2019
Provides Priority Regulatory Review of AI-Enabled Diagnostic for Fast-Progressing Kidney Disease NEW YORK, May 2, 2019 /PRNewswire/ --  Renalytix AI plc  (LON: RENX), a developer of artificial intelligence-enabled clinical diagnostics for kidney disease, announced today that it has been granted
Displaying 61 - 70 of 70